메뉴 건너뛰기




Volumn 23, Issue 4, 2007, Pages 406-412

Challenges and progress in pediatric inflammatory bowel disease

Author keywords

Crohn's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; FLUORODEOXYGLUCOSE F 18; FUNGUS ANTIBODY; HEPCIDIN; HYDROCORTISONE; INFLIXIMAB; MANNITOL; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATALIZUMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; POLYMER; RECOMBINANT GROWTH HORMONE; STEROID; TACROLIMUS; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VITAMIN D;

EID: 34249943921     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3281b115c2     Document Type: Review
Times cited : (15)

References (33)
  • 1
    • 33747397951 scopus 로고    scopus 로고
    • Incidence of inflammatory bowel disease in Finnish children, 1987-2003
    • Turunen P, Kolho K-L, Auvinin A, et al. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006; 12:677-683.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 677-683
    • Turunen, P.1    Kolho, K.-L.2    Auvinin, A.3
  • 2
    • 33748449654 scopus 로고    scopus 로고
    • Challenges in pediatric inflammatory bowel disease
    • This report outlines the research goals and initiatives of the CCFA addressing improved diagnosis and care of children with IBD
    • Bousvaros A, Sylvester F, Kugathasan S, et al. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:885-913. This report outlines the research goals and initiatives of the CCFA addressing improved diagnosis and care of children with IBD.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 885-913
    • Bousvaros, A.1    Sylvester, F.2    Kugathasan, S.3
  • 3
    • 19944426172 scopus 로고    scopus 로고
    • Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry
    • Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146:35-40.
    • (2005) J Pediatr , vol.146 , pp. 35-40
    • Heyman, M.B.1    Kirschner, B.S.2    Gold, B.D.3
  • 5
    • 33646486116 scopus 로고    scopus 로고
    • Risk factors for initial surgery in pediatric patients with Crohn's disease
    • Data from this large-scale study from the Pedi IBD Consortium registry may assist clinicians in identifying patients at high risk of the development of complications of Crohn's disease. These individuals may benefit the most from earlier and more intensive therapies
    • Gupta N, Cohen SA, Bostrom AG, et al. Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology 2006; 130:1069-1077. Data from this large-scale study from the Pedi IBD Consortium registry may assist clinicians in identifying patients at high risk of the development of complications of Crohn's disease. These individuals may benefit the most from earlier and more intensive therapies.
    • (2006) Gastroenterology , vol.130 , pp. 1069-1077
    • Gupta, N.1    Cohen, S.A.2    Bostrom, A.G.3
  • 6
    • 33644755927 scopus 로고    scopus 로고
    • Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients
    • Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol 2006; 101:645-652.
    • (2006) Am J Gastroenterol , vol.101 , pp. 645-652
    • Amre, D.K.1    Lu, S.E.2    Costea, F.3    Seidman, E.G.4
  • 7
    • 33644908022 scopus 로고    scopus 로고
    • Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression
    • Dubinsky MC, Lin Y-C, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol 2006; 101:360-367.
    • (2006) Am J Gastroenterol , vol.101 , pp. 360-367
    • Dubinsky, M.C.1    Lin, Y.-C.2    Dutridge, D.3
  • 8
    • 30844462134 scopus 로고    scopus 로고
    • Bowel magnetic resonance imaging of pediatric patients with oral mannitol MRI compared to endoscopy and intestinal ultrasound
    • Borthne AS, Abdelnoor M, Rugtveit J, et al. Bowel magnetic resonance imaging of pediatric patients with oral mannitol MRI compared to endoscopy and intestinal ultrasound. Eur Radiol 2006; 16:207-214.
    • (2006) Eur Radiol , vol.16 , pp. 207-214
    • Borthne, A.S.1    Abdelnoor, M.2    Rugtveit, J.3
  • 9
    • 17044426570 scopus 로고    scopus 로고
    • Dynamic color Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects
    • Scholbach T, Herrero I, Scholbach J. Dynamic color Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects. J Pediatr Gastroenterol Nutr 2004; 39:524-528.
    • (2004) J Pediatr Gastroenterol Nutr , vol.39 , pp. 524-528
    • Scholbach, T.1    Herrero, I.2    Scholbach, J.3
  • 10
    • 33749016032 scopus 로고    scopus 로고
    • High diagnostic value of 18F-FDGPET in pediatric patients with chronic inflammatory bowel disease
    • Loffler M, Weckesser M, Franzius C, et al. High diagnostic value of 18F-FDGPET in pediatric patients with chronic inflammatory bowel disease. Ann NY Acad Sci 2006; 1072:379-385.
    • (2006) Ann NY Acad Sci , vol.1072 , pp. 379-385
    • Loffler, M.1    Weckesser, M.2    Franzius, C.3
  • 11
    • 24644491218 scopus 로고    scopus 로고
    • Positron emission tomography in the investigation of pediatric inflammatory bowel disease
    • Lemberg DA, Issenman RM, Cawdron R, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:733-738.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 733-738
    • Lemberg, D.A.1    Issenman, R.M.2    Cawdron, R.3
  • 12
    • 17644404772 scopus 로고    scopus 로고
    • Wireless capsule endoscopy for obscure small-bowel disorders: Final results of the first pediatric controlled trial
    • Sant'Anna AM, Dubois J, Miron M, et al. Wireless capsule endoscopy for obscure small-bowel disorders: final results of the first pediatric controlled trial. Clin Gastroenterol Hepatol 2005; 3:1-7.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 1-7
    • Sant'Anna, A.M.1    Dubois, J.2    Miron, M.3
  • 13
    • 34249933462 scopus 로고    scopus 로고
    • Ge ZZ, Chen HY, Gao YJ, et al. Clinical application of wireless capsule endoscopy in pediatric patients for suspected small bowel diseases. Eur J Pediatr 2006; November:1-5. E-pub ahead of print.
    • Ge ZZ, Chen HY, Gao YJ, et al. Clinical application of wireless capsule endoscopy in pediatric patients for suspected small bowel diseases. Eur J Pediatr 2006; November:1-5. E-pub ahead of print.
  • 14
    • 33748210698 scopus 로고    scopus 로고
    • The natural history of corticosteroid therapy for ulcerative colitis in children
    • Hyams J, Markowitz J, Lerer T, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006; 4:1118-1123.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 1118-1123
    • Hyams, J.1    Markowitz, J.2    Lerer, T.3
  • 15
    • 33744778418 scopus 로고    scopus 로고
    • Borrelli O, Cordischi L, Cirulli M, et al. Polymer diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4:744-753.
    • Borrelli O, Cordischi L, Cirulli M, et al. Polymer diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4:744-753.
  • 16
    • 33750519460 scopus 로고    scopus 로고
    • Efficacy of methotrexate in pediatric Crohn's disease: A French multicenter study
    • Uhlen S, Belbouab R, Narebski K, et al. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis 2006; 12:1053-1057.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 1053-1057
    • Uhlen, S.1    Belbouab, R.2    Narebski, K.3
  • 17
    • 0027237384 scopus 로고
    • Growth failure in children with inflammatory bowel disease: A prospective study
    • Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993; 105:681-691.
    • (1993) Gastroenterology , vol.105 , pp. 681-691
    • Motil, K.J.1    Grand, R.J.2    Davis-Kraft, L.3
  • 18
    • 18944369159 scopus 로고    scopus 로고
    • Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: A pilot study
    • Calenda KA, Schornagel IL, Sadeghi-Nejad A, Grand RJ. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study. Inflamm Bowel Dis 2005; 11:435-441.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 435-441
    • Calenda, K.A.1    Schornagel, I.L.2    Sadeghi-Nejad, A.3    Grand, R.J.4
  • 19
    • 9144234882 scopus 로고    scopus 로고
    • Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease
    • Lamireau T, Cezard JP, Dabadie A, et al. Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease. Inflamm Bowel Dis 2004; 10:745-750.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 745-750
    • Lamireau, T.1    Cezard, J.P.2    Dabadie, A.3
  • 20
    • 13144265888 scopus 로고    scopus 로고
    • Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    • Friesen CA, Calabro C, Christenson K, et al. Safety of infliximab treatment in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004; 39:265-269.
    • (2004) J Pediatr Gastroenterol Nutr , vol.39 , pp. 265-269
    • Friesen, C.A.1    Calabro, C.2    Christenson, K.3
  • 21
    • 18944367848 scopus 로고    scopus 로고
    • Premedication and infusion reactions with infliximab: Results from a pediatric inflammatory bowel disease consortium
    • Jacobstein DA, Markowitz JE, Kirschner BS, et al. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium. Inflamm Bowel Dis 2005; 11:442-446.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 442-446
    • Jacobstein, D.A.1    Markowitz, J.E.2    Kirschner, B.S.3
  • 22
    • 15944366494 scopus 로고    scopus 로고
    • Infliximab efficacy in pediatric ulcerative colitis
    • Eidelwein AP, Cuffari C, Abadom V, et al. Infliximab efficacy in pediatric ulcerative colitis. Inflamm Bowel Dis 2005; 11:213-218.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 213-218
    • Eidelwein, A.P.1    Cuffari, C.2    Abadom, V.3
  • 23
    • 13944252969 scopus 로고    scopus 로고
    • Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease
    • Thayu M, Markowitz JE, Mamula P, et al. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease. J Pediatr Gastroenterol Nutr 2005; 40:220-222.
    • (2005) J Pediatr Gastroenterol Nutr , vol.40 , pp. 220-222
    • Thayu, M.1    Markowitz, J.E.2    Mamula, P.3
  • 24
    • 20044382590 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid- dependent Crohn's disease
    • Feagan BG, Sandborn WJ, Baker JP, et al. A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid- dependent Crohn's disease. Aliment Pharmacol Ther 2005; 21:373-384.
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 373-384
    • Feagan, B.G.1    Sandborn, W.J.2    Baker, J.P.3
  • 25
    • 4644325814 scopus 로고    scopus 로고
    • CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: A randomised, double blind, placebo controlled trial
    • Sandborn WJ, Feagan BG, Radford-Smith G, et al. CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial. Gut 2004; 53:1485-1493.
    • (2004) Gut , vol.53 , pp. 1485-1493
    • Sandborn, W.J.1    Feagan, B.G.2    Radford-Smith, G.3
  • 26
    • 9144261186 scopus 로고    scopus 로고
    • CDP571, a humanized antitumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's disease
    • Mamula P, Cohen SA, Ferry GD, et al. CDP571, a humanized antitumor necrosis factor-alpha monoclonal antibody in pediatric Crohn's disease. Inflamm Bowel Dis 2004; 10:723-730.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 723-730
    • Mamula, P.1    Cohen, S.A.2    Ferry, G.D.3
  • 27
    • 33846634683 scopus 로고    scopus 로고
    • Natalizumab therapy for moderate to severe Crohn disease in adolescents
    • Although a promising biological agent, it is unlikely that natalizumab therapy will become a widespread alternative for use in the treatment of children with IBD
    • Hyams JS, Wilson DC, Thomas A, et al. Natalizumab therapy for moderate to severe Crohn disease in adolescents. J Pediatr Gastroenterol Nutr 2007; 44:185-191. Although a promising biological agent, it is unlikely that natalizumab therapy will become a widespread alternative for use in the treatment of children with IBD.
    • (2007) J Pediatr Gastroenterol Nutr , vol.44 , pp. 185-191
    • Hyams, J.S.1    Wilson, D.C.2    Thomas, A.3
  • 28
    • 33750958905 scopus 로고    scopus 로고
    • Vitamin D status in children and young adults with inflammatory bowel disease
    • Pappa HM, Gordon CM, Saslowsky TM, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006; 118:1950-1961.
    • (2006) Pediatrics , vol.118 , pp. 1950-1961
    • Pappa, H.M.1    Gordon, C.M.2    Saslowsky, T.M.3
  • 29
    • 33751579324 scopus 로고    scopus 로고
    • Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation
    • The assessment of hepcidin levels may play a role in the management of a broad range of autoimmune inflammatory processes
    • Semrin G, Fishman DS, Bousvaros A, et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006; 12:1101-1106. The assessment of hepcidin levels may play a role in the management of a broad range of autoimmune inflammatory processes.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 1101-1106
    • Semrin, G.1    Fishman, D.S.2    Bousvaros, A.3
  • 30
    • 33747427701 scopus 로고    scopus 로고
    • Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease
    • Otley AR, Griffiths AM, Hale S, et al. Health-related quality of life in the first year after a diagnosis of pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:684-691.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 684-691
    • Otley, A.R.1    Griffiths, A.M.2    Hale, S.3
  • 31
    • 17444424968 scopus 로고    scopus 로고
    • Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease
    • De Boer M, Grootenhuis M, Derkz B, et al. Health-related quality of life and psychosocial functioning of adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:400-406.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 400-406
    • De Boer, M.1    Grootenhuis, M.2    Derkz, B.3
  • 32
    • 18244395881 scopus 로고    scopus 로고
    • Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America
    • Shepanski MA, Hurd LB, Culton K, et al. Health-related quality of life improves in children and adolescents with inflammatory bowel disease after attending a camp sponsored by the Crohn's and Colitis Foundation of America. Inflamm Bowel Dis 2005; 11:164-170.
    • (2005) Inflamm Bowel Dis , vol.11 , pp. 164-170
    • Shepanski, M.A.1    Hurd, L.B.2    Culton, K.3
  • 33
    • 29744451539 scopus 로고    scopus 로고
    • Educate, communicate, anticipate - practical recommendations for transitioning adolescents with IBD to adult healthcare
    • Hait E, Arnold JH, Fishman LN. Educate, communicate, anticipate - practical recommendations for transitioning adolescents with IBD to adult healthcare. Inflamm Bowel Dis 2006; 12:70-73.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 70-73
    • Hait, E.1    Arnold, J.H.2    Fishman, L.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.